Farther Finance Advisors’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$392K Buy
10,707
+8,923
+500% +$324K ﹤0.01% 1791
2026
Q2
$63.1K Sell
1,784
-166
-9% -$4.91K ﹤0.01% 3068
2026
Q1
$54.3K Sell
1,950
-1,650
-46% -$42.4K ﹤0.01% 2946
2025
Q4
$78.1K Buy
3,600
+1,345
+60% +$26.5K ﹤0.01% 2504
2025
Q3
$34.1K Buy
2,255
+188
+9% +$2.33K ﹤0.01% 2685
2025
Q2
$23.3K Buy
2,067
+2,059
+25,738% +$22.3K ﹤0.01% 2583
2025
Q1
$79 Hold
8
– – ﹤0.01% 4094
2024
Q4
$95 Sell
8
-14
-64% -$166 ﹤0.01% 3792
2024
Q3
$254 Buy
+22
New +$250 ﹤0.01% 3594
2023
Q1
– Sell
-67,008
Closed -$535K – 2414
2022
Q4
$535K Buy
+67,008
New +$373K 0.21% 94

Other funds holding ROIV

Farther Finance Advisors's ROIV Position: Q3 2026 in Review

Farther Finance Advisors increased its Roivant Sciences (ROIV) stake by 500% in Q3 2026, buying an estimated $324K and bringing the position to 10,707 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1791.

Farther Finance Advisors first reported a position in ROIV in Q4 2022 and has held it in 10 quarters since. The position peaked at $535K in Q4 2022. 20 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Farther Finance Advisors held 10,707 shares of Roivant Sciences worth $392K as of Q3 2026.
  • Farther Finance Advisors bought 8,923 Roivant Sciences shares in Q3 2026, an estimated $324K.
  • Roivant Sciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1791 holding.
  • Farther Finance Advisors first reported a position in Roivant Sciences in Q4 2022 and has held it in 10 quarters since.
  • Farther Finance Advisors's Roivant Sciences position peaked at $535K in Q4 2022.
  • 20 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.